Skip to main content

Table 4 Comparison of clinical characteristics and CT parameters in GLDIS T2DM patients and non-GLDIS T2DM patients after propensity matching

From: Coronary inflammation based on pericoronary adipose tissue attenuation in type 2 diabetic mellitus: effect of diabetes management

Variables

GLDIS T2DM patients

Non-GLDIS T2DM patients

P

n

92

92

 

Age (years)

62.08 ± 11.17

62.58 ± 9.01

0.739

Male sex, n (%)

45 (48.9)

45 (48.9)

1.000

Body mass index (kg/m2)

25.01 ± 3.88

24.39 ± 3.24

0.344

Smoking, n (%)

19 (20.7)

18 (19.6)

0.854

Hypertension, n (%)

59 (64.1)

56 (60.9)

0.648

Dyslipidemia, n (%)

20 (23.0)

28 (32.9)

0.146

Statin, n (%)

39 (42.4)

31 (33.7)

0.224

Tube voltage of CT acquisition

  

0.499

 

100 kVp, n (%)

51 (55.4)

43 (46.7)

  

120 kVp, n (%)

36 (39.1)

43 (46.7)

  

140 kVp, n (%)

5 (5.4)

6 (6.5)

  

LAD-PCAT (HU)

− 78.11 ± 8.01

− 75.04 ± 8.26

0.022

LCX-PCAT (HU)

− 71.10 ± 8.13

− 68.31 ± 7.90

0.037

RCA-PCAT (HU)

− 78.17 ± 8.64

− 73.35 ± 9.32

0.001

  1. Data are presented as means ± standard deviations or the median (25th and 75th percentile), with the interquartile range in parentheses or number (%)
  2. T2DM type 2 diabetes mellitus, GLDIS glucose-lowering drug interventions, PCAT Pericoronary adipose tissue, LAD left anterior descending artery, LCX left circumflex artery, RCA right coronary artery